Riff L, Hutchinson R
Hosp Formul. 1988 Nov;23(11):901-4, 907-8.
In this exclusive Hospital Formulary interview, Louise Riff, MD, and Richard Hutchinson, PharmD, highlight the challenges of their 15-year tenure as the Chairman and Secretary of the University of Illinois Hospital P & T Committee. While continuity in formal leadership has been advantageous, they also attribute part of their success to the diverse informal leadership that develops each year. Drs. Riff and Hutchinson discuss how the P & T Committee has become accomplished at making what once were controversial decisions, such as removing the number one drug from their formulary as a cost-containment strategy. They also describe the recent development of an improved ADR reporting system and the progress in exchanging formulary decisions with neighboring hospitals. This P & T Committee, however, expresses some discomfort with the evaluation of high-tech drug products, since significant cost implications without therapeutic guarantees create new dimensions in decision-making for their Committee.
在这次独家的医院处方集访谈中，医学博士路易丝·里夫和药学博士理查德·哈钦森强调了他们担任伊利诺伊大学医院药品与治疗学委员会主席和秘书15年期间所面临的挑战。虽然正式领导的连续性带来了好处，但他们也将部分成功归功于每年发展起来的多样化非正式领导。里夫博士和哈钦森博士讨论了药品与治疗学委员会如何在做出曾经有争议的决策方面取得了成就，比如作为成本控制策略从他们的处方集中移除头号药物。他们还描述了改进后的药品不良反应报告系统的最新发展以及与邻近医院交换处方集决策方面的进展。然而，这个药品与治疗学委员会对高科技药品的评估表示有些不安，因为巨大的成本影响且没有治疗保障给他们委员会的决策带来了新的维度。
